Nonalcoholic fatty liver disease (NAFLD) is a burgeoning medical problem that affects 20–34% of the population in Western countries (1). Although the prevalence of NAFLD is somewhat lower in Asia, the frequency is increasing and the disorder is now being seen in younger individuals (2,3).
NAFLD is a multifactorial disorder. Major risk factors include obesity, insulin resistance and a variation (rs738409) in patatin-like phospholipase domain-containing protein 3 (PNPLA3) that substitutes methionine for isoleucine at residue 148 (I148M) (1). Only one prior study has examined the relationship between this variant and NAFLD in China. In that study the variant was associated with fibrosis, but not steatosis (4). Here we examined the relationship between PNPLA3-I148M and liver TG content in 203 unrelated adults with NAFLD who were recruited from an outpatient liver clinic at the First Hospital of China Medical University. Hepatic steatosis was diagnosed by liver ultrasonography using established criteria (5); all other known causes of hepatic steatosis were excluded (see legend to Table 1). A total of 202 ethnically-matched controls with normal liver enzyme levels and no steatosis by ultrasonography were recruited from primary care outpatient clinics at the same institution.
After obtaining IRB-approved written informed consent, fasting blood samples were collected. A higher proportion of cases were men (60% versus 49%; nominal P=0.04) and their mean age was greater than that of controls (46.6 versus 41.9 years old; P=1.8×10−4). Levels of circulating liver enzymes, LDL-C, triglyceride and glucose were significantly higher, and HDL-C levels were significantly lower, in cases than in controls (Table 1).
The frequency of the I148M variant was significantly higher in cases (0.45) than in controls (0.31) (P=1.5×10−4) and the association remained robust after adjusting for age, sex, and BMI (P=3.7×10−3) (Fig. 1). The odds ratio for hepatic steatosis was 1.73 for each copy of the G allele (95% CI: [1.49, 1.99]). The I148M variant was also associated with higher serum ALT levels (nominal P=1.1×10−7, adjusted P=2.0×10−6), but not with BMI, fasting glucose or with lipid/lipoprotein levels (data not shown).
This is the first report to document an association between PNPLA3-I148M and hepatic steatosis in a population from mainland China. The relatively high frequency of the risk allele in China makes it imperative that efforts are made to control weight gain with increasing urbanization and adoption of Western eating habits.